Rapid characterization of covalent modifications to rat brain mitochondrial proteins after ex vivo exposure to 4-hydroxy-2-nonenal by liquid chromatography-tandem mass spectrometry using data-dependent and neutral loss-driven MS3 acquisition

Journal of Mass Spectrometry

Volumn 42, Issue 12, 2007, Pages 1599-1605

  Stevens Jr , Stanley M ^a   Rauniyar, Navin ^a   Prokai, Laszlo ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

4 hydroxy 2 nonenal; Fourier transform ion cyclotron resonance mass spectrometry; Mitochondria; MS3; Proteomics; Tandem mass spectrometry

Indexed keywords

BRAIN; CYCLOTRON RESONANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPIDS; MASS SPECTROMETRY; RATS;

4-HYDROXY-2-NONENAL; FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MITOCHONDRIA; PROTEOMICS; TANDEM MASS SPECTROMETRY;

PROTEINS;

4 HYDROXYNONENAL; HISTIDINE; MITOCHONDRIAL PROTEIN;

ADDUCTION; ANIMAL EXPERIMENT; BRAIN MITOCHONDRION; CELL FRACTIONATION; COLLISIONALLY ACTIVATED DISSOCIATION; CONFERENCE PAPER; EX VIVO STUDY; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFORMATION PROCESSING; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; ION TRAP MASS SPECTROMETRY; LIPID PEROXIDATION; MALE; METHODOLOGY; MICHAEL ADDITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; TANDEM MASS SPECTROMETRY;

ALDEHYDES; ANIMALS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOTRONS; DATA INTERPRETATION, STATISTICAL; DATABASES, PROTEIN; FOURIER ANALYSIS; INDICATORS AND REAGENTS; MALE; MITOCHONDRIAL PROTEINS; PEPTIDE HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 38149060199     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1349     Document Type: Conference Paper

References (31)

1. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radical Biology and Medicine 2004; 37: 755.
2. Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends in Pharmacological Sciences 2006; 27: 639.
3. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. Journal of Cellular and Molecular Medicine 2006; 10: 389.
4. Esterbauer H, Zollner H. Methods for determination of aldehydic lipid peroxidation products. Free Radical Biology and Medicine 1989; 7: 197.
5. Poli G, Schaur RJ. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000; 50: 315.
6. Carini M, Aldini G, Facino RM. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mess Spectrometry Reviews 2004; 23: 281.-
7. Musatov A, Carroll CA, Liu YC, Henderson GI, Weintraub ST, Robinson NC. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 2002; 41: 8212.
8. Bolgar MS, Yang CY, Gaskell SJ. First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. Journal of Biological Chemistry 1996; 271: 27999.
9. Bennaars-Eiden A, Higgins L, Hertzel AV, Kapphahn RJ, Ferrington DA, Bernlohr DA. Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. Journal of Biological Chemistry 2002; 277: 50693.
10. Crabb JW, O'Neil J, Miyagi M, West K, Hoff HF. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Science 2002; 11: 831.
11. Ishii T, Tatsuda E, Kumazawa S, Nakayama T, Uchida K. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 2003; 42: 3474.
12. Szweda LI, Uchida K, Tsai L, Stadtman ER. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. Journal of Biological Chemistry 1993; 268: 3342.
13. Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, Schneider RI, Broyles RH, Bachmann M, Hensley K. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radical Biology and Medicine 2005; 38: 719.
14. Roe MR, Xie H, Bandhakavi S, Griffin TJ. Proteomic mapping of 4-hydroxynonenal protein modification sites by solid-phase hydrazide chemistry and mass spectrometry. Analytical Chemistry 2007; 79: 3747.
15. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 1990; 186: 464.
16. Meany DL, Xie H, Thompson LV, Arriaga EA, Griffin TJ. Identification of carbonylated proteins from enriched rat skeletal muscle mitochondria using affinity chromatography-stable isotope labeling and tandem mass spectrometry. Proteomics 2007; 7: 1150.
17. Chavez J, Wu J, Han B, Chung WG, Maier CS. New role for an old probe: affinity labeling of oxylipid protein conjugates by N′- aminooxymethylcarbonylhydrazino d-biotin. Analytical Chemistry 2006; 78: 6847.
18. Han B, Stevens JF, Maier CS. Design, synthesis, and application of a hydrazide-functionalized isotope-coded affinity tag for the quantification of oxylipid-protein conjugates. Analytical Chemistry 2007; 79: 3342.
19. Stevens SM Jr, Zharikova AD, Prokai L. Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain. Brain Research-Molecular Brain Research 2003; 117: 116.
20. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Analytical Chemistry 2002; 74: 5383.
21. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Analytical Chemistry 2003; 75: 4646.
22. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991; 11: 81.
23. Bolgar MS, Gaskell SJ. Determination of the sites of 4-hydroxy-2-nonenal adduction to protein by electrospray tandem mass spectrometry. Analytical Chemistry 1996; 68: 2325.
24. Hussain SN, Matar G, Barreiro E, Florian M, Divangahi M, Vassilakopoulos T. Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats. American Journal of Physiology-Lung Cellular and Molecular Physiology 2006; 290: 996.
25. Yan L-J, Levine RL, Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 11168.
26. Das N, Levine RL, Orr WC, Sohal RS. Selectivity of protein oxidative damage during aging in Drosophila melanogaster. Biochemical Journal 2001; 360: 209.
27. Prokai L, Yan L-J, Vera-Serrano JL, Stevens SM Jr, Forster MJ. Mass spectrometry-based identification of mitochondrial proteins susceptible to age-related oxidative carbonylation in the rat brain. Journal of Mass Spectrometry, in press, DOI: 10.1002/jms.1345.
28. Powell CS, Jackson RM. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. American Journal of Physiology-Lung Cellular and Molecular Physiology 2003; 285: 189.
29. Trotti D, Rolfs A, Danbolt NC, Brown RH Jr, Hediger MA. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nature Neuroscience 1999; 2: 427.
30. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Annale of Neurology 1998; 44: 819.
31. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Aβ1-42. Journal of Neurochemistry 2001; 78: 413.